Selected research
Industry Research
Veterinary Anti-Infectives Industry Research Report 2026
Market perspective
The global Veterinary Anti-Infectives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Veterinary Anti-Infectives market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Veterinary Anti-Infectives market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Veterinary Anti-Infectives market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Veterinary Anti-Infectives include Zoetis Animal Healthcare, Merck, Bayer Healthcare, Virbac, Merial (Sanofi), Elanco, Ceva Animal Health and Boehringer Ingelheim, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Veterinary Anti-Infectives market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Veterinary Anti-Infectives.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Anti-Infectives Market by Company
Zoetis Animal Healthcare
Merck
Bayer Healthcare
Virbac
Merial (Sanofi)
Elanco
Ceva Animal Health
Boehringer Ingelheim
Veterinary Anti-Infectives Segment by Type
Oxytetracycline
Freeze-dried Ceftiofur
Marbofloxacin
Florfenicol
Aminosidine
Beta-lactams
Veterinary Anti-Infectives Segment by Application
Companion Animals
Farm Animals
Others
Veterinary Anti-Infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Anti-Infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Veterinary Anti-Infectives companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oxytetracycline
- Freeze-dried Ceftiofur
- Marbofloxacin
- Florfenicol
- Aminosidine
- Beta-lactams
Applications
- Companion Animals
- Farm Animals
- Others
Companies covered
- Zoetis Animal Healthcare
- Merck
- Bayer Healthcare
- Virbac
- Merial (Sanofi)
- Elanco
- Ceva Animal Health
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Veterinary Anti-Infectives by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oxytetracycline
- 2.2.3 Freeze-dried Ceftiofur
- 2.2.4 Marbofloxacin
- 2.2.5 Florfenicol
- 2.2.6 Aminosidine
- 2.2.7 Beta-lactams
- 2.3 Veterinary Anti-Infectives by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Companion Animals
- 2.3.3 Farm Animals
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Veterinary Anti-Infectives Breakdown Data by Type
- 3.1 Global Veterinary Anti-Infectives Historic Market Size by Type (2021-2026)
- 3.2 Global Veterinary Anti-Infectives Forecasted Market Size by Type (2027-2032)
4 Veterinary Anti-Infectives Breakdown Data by Application
- 4.1 Global Veterinary Anti-Infectives Historic Market Size by Application (2021-2026)
- 4.2 Global Veterinary Anti-Infectives Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Veterinary Anti-Infectives Market Perspective (2021-2032)
- 5.2 Global Veterinary Anti-Infectives Growth Trends by Region
- 5.2.1 Global Veterinary Anti-Infectives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Veterinary Anti-Infectives Historic Market Size by Region (2021-2026)
- 5.2.3 Veterinary Anti-Infectives Forecasted Market Size by Region (2027-2032)
- 5.3 Veterinary Anti-Infectives Market Dynamics
- 5.3.1 Veterinary Anti-Infectives Industry Trends
- 5.3.2 Veterinary Anti-Infectives Market Drivers
- 5.3.3 Veterinary Anti-Infectives Market Challenges
- 5.3.4 Veterinary Anti-Infectives Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Veterinary Anti-Infectives Players by Revenue
- 6.1.1 Global Top Veterinary Anti-Infectives Players by Revenue (2021-2026)
- 6.1.2 Global Veterinary Anti-Infectives Revenue Market Share by Players (2021-2026)
- 6.2 Global Veterinary Anti-Infectives Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Veterinary Anti-Infectives Head Office and Area Served
- 6.4 Global Veterinary Anti-Infectives Players, Product Type & Application
- 6.5 Global Veterinary Anti-Infectives Manufacturers Established Date
- 6.6 Global Veterinary Anti-Infectives Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Veterinary Anti-Infectives Market Size (2021-2032)
- 7.2 North America Veterinary Anti-Infectives Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Veterinary Anti-Infectives Market Size by Country (2021-2026)
- 7.4 North America Veterinary Anti-Infectives Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Veterinary Anti-Infectives Market Size (2021-2032)
- 8.2 Europe Veterinary Anti-Infectives Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Veterinary Anti-Infectives Market Size by Country (2021-2026)
- 8.4 Europe Veterinary Anti-Infectives Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Veterinary Anti-Infectives Market Size (2021-2032)
- 9.2 Asia-Pacific Veterinary Anti-Infectives Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Veterinary Anti-Infectives Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Veterinary Anti-Infectives Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Veterinary Anti-Infectives Market Size (2021-2032)
- 10.2 South America Veterinary Anti-Infectives Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Veterinary Anti-Infectives Market Size by Country (2021-2026)
- 10.4 South America Veterinary Anti-Infectives Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Veterinary Anti-Infectives Market Size (2021-2032)
- 11.2 Middle East & Africa Veterinary Anti-Infectives Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Veterinary Anti-Infectives Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Veterinary Anti-Infectives Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zoetis Animal Healthcare
- 12.1.1 Zoetis Animal Healthcare Company Information
- 12.1.2 Zoetis Animal Healthcare Business Overview
- 12.1.3 Zoetis Animal Healthcare Revenue in Veterinary Anti-Infectives Business (2021-2026)
- 12.1.4 Zoetis Animal Healthcare Veterinary Anti-Infectives Product Portfolio
- 12.1.5 Zoetis Animal Healthcare Recent Developments
- 12.2 Merck
- 12.2.1 Merck Company Information
- 12.2.2 Merck Business Overview
- 12.2.3 Merck Revenue in Veterinary Anti-Infectives Business (2021-2026)
- 12.2.4 Merck Veterinary Anti-Infectives Product Portfolio
- 12.2.5 Merck Recent Developments
- 12.3 Bayer Healthcare
- 12.3.1 Bayer Healthcare Company Information
- 12.3.2 Bayer Healthcare Business Overview
- 12.3.3 Bayer Healthcare Revenue in Veterinary Anti-Infectives Business (2021-2026)
- 12.3.4 Bayer Healthcare Veterinary Anti-Infectives Product Portfolio
- 12.3.5 Bayer Healthcare Recent Developments
- 12.4 Virbac
- 12.4.1 Virbac Company Information
- 12.4.2 Virbac Business Overview
- 12.4.3 Virbac Revenue in Veterinary Anti-Infectives Business (2021-2026)
- 12.4.4 Virbac Veterinary Anti-Infectives Product Portfolio
- 12.4.5 Virbac Recent Developments
- 12.5 Merial (Sanofi)
- 12.5.1 Merial (Sanofi) Company Information
- 12.5.2 Merial (Sanofi) Business Overview
- 12.5.3 Merial (Sanofi) Revenue in Veterinary Anti-Infectives Business (2021-2026)
- 12.5.4 Merial (Sanofi) Veterinary Anti-Infectives Product Portfolio
- 12.5.5 Merial (Sanofi) Recent Developments
- 12.6 Elanco
- 12.6.1 Elanco Company Information
- 12.6.2 Elanco Business Overview
- 12.6.3 Elanco Revenue in Veterinary Anti-Infectives Business (2021-2026)
- 12.6.4 Elanco Veterinary Anti-Infectives Product Portfolio
- 12.6.5 Elanco Recent Developments
- 12.7 Ceva Animal Health
- 12.7.1 Ceva Animal Health Company Information
- 12.7.2 Ceva Animal Health Business Overview
- 12.7.3 Ceva Animal Health Revenue in Veterinary Anti-Infectives Business (2021-2026)
- 12.7.4 Ceva Animal Health Veterinary Anti-Infectives Product Portfolio
- 12.7.5 Ceva Animal Health Recent Developments
- 12.8 Boehringer Ingelheim
- 12.8.1 Boehringer Ingelheim Company Information
- 12.8.2 Boehringer Ingelheim Business Overview
- 12.8.3 Boehringer Ingelheim Revenue in Veterinary Anti-Infectives Business (2021-2026)
- 12.8.4 Boehringer Ingelheim Veterinary Anti-Infectives Product Portfolio
- 12.8.5 Boehringer Ingelheim Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst